Company Overview

Development Stage

About the Company

山东泰邦生物制品有限公司是在山东省生物制品研究所与外商于二00二年十一月成立的合资企业。是以血液制品、基因工程产品和生化制药为主体的,集科研、生产、经营一体化的*重点高新技术企业。是山东*定点的国家血液制品生产企业。公司总部设在山东泰安。在泰安建有一个血液制品生产基地和血液制品研究中心。公司现有人血白蛋白、人免疫球蛋白、静注人免疫球蛋白(pH4)、乙型肝炎人免疫球蛋白、狂犬病人免疫球蛋白、破伤风人免疫球蛋白、人凝血因子Ⅷ、人凝血酶原复合物等八个品种,23个规格的产品,产品批签发合格率100%,优质的产品赢得了市场的青睐。合资以来,销售收入年增长率超过50%。泰邦生物成立六年来,生产经营迅速扩大,经济取得长足发展。企业的综合实力从*初的血液制品行业第三梯队上升为*梯队,产值利润等各项经济指标统计的综合实力排名,去年居全国血液制品同行业位列前3位。目前,公司拥有一支国际化的管理团队,其中境外高管人士近半数,建立起了与国际化运作相适应的管理队伍。2009年12月公司控股股东—China Biologic Products, Inc.(中国生物制品)于美国纳斯达克成功上市(交易代码为NASDAQ:CBPO),为公司的发展提供了强大的资本支持, 自2009年以来,中国生物制品连续三次荣登《福布斯》公布2009亚洲200家*佳中小企业榜单。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Financing History (1 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 3亿美元
  • Investor: GIC新加坡政府投资公司,...

How Fast Is Hiring Growing? (3 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 65%
  • 2024: Up 360%
  • 2023: Up 400%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 山东泰邦生物制品有限公司 growing? 2025: 38 openings (up 65%), 2024: 23 openings (up 360%), 2023: 5 openings (up 400%), 2022: 1 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (12 records)

Manage
salary range: 2K - 15K, 58.3% of roles pay ¥2-8K
Note: salary statistics are based on 12 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 山东泰邦生物制品有限公司?58.3% of positions earn 2-8K, Undergraduate salary: ¥。医疗卫生/美容保健类 average salary ¥10.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 医疗卫生/美容保健类
    41.7% of total 41.7%
  • 其他类
    25% of total 25%
  • 工厂生产类
    16.7% of total 16.7%
  • 法律类
    16.7% of total 16.7%

Education

  • 本科
    41.7% of total 41.7%
  • 大专
    25% of total 25%
  • 不限
    25% of total 25%
  • 高中
    8.3% of total 8.3%

Experience

  • 不限
    50% of total 50%
  • 3-5年
    33.3% of total 33.3%
  • 1-3年
    8.3% of total 8.3%
  • 5-10年
    8.3% of total 8.3%
View Detailed Analysis

What does 山东泰邦生物制品有限公司 require? Who is 山东泰邦生物制品有限公司 hiring? recruitment: 医疗卫生/美容保健类占比最多占41.7%,其次是其他类占25%. What education can get in at ? 本科占比最多占41.7%,其次是大专占25%. Work experience required at ? 不限占比最多占50%,其次是3-5年占33.3%. Where are the job locations at ? 泰安占比最多占100%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 16,000万(元)
Legal Representative: 陈云华
Date Established:
Credit Code: 9137090074339483X2
Registered Address: 山东省泰安市高新区龙泉路5666号

Partners & Suppliers

海尔血液技术向泰邦生物销售血浆采集系统 Source
供应商 血液制品企业
提供废水处理 Source
供应商 制药行业
战略合作协议,华润医药商业作为山东泰邦生物制品有限公司血液制品的主要分销商之一,负责产品在部分区域的销售和配送 Source
合作客户 医药商业

People who follow this company also follow

Competitors (Similar Companies)

制药/药业 软膏剂 凝胶剂 原料药
生命科学 生物制品 医疗科技 药物研发
低压电器 输变电设备 输变电 开关变压器
医药 疫苗 新药研发 血液制品
石膏 建材 石膏板 轻钢
绿色农业 生物安全 生物制品 兽药
压力容器 高端装备 锅炉 重工
服务外包 数据挖掘 B2B 通信系统
食品 白酒 浓香型白酒 酒业
钢材 钢筋 碳素钢 优质碳素钢
生产 阻燃剂 催化剂 工业
啤酒 生产 酵母 直营
农业 叶面肥 复合肥料 肥料
制药/药业 纳米制剂 研发 生产
电力 能源 导线 交联电缆

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates